KNB Kanabo Group Plc

0.0000USD0.0022 GBp · LSE0.00%Mkt Cap: 1.87M USDP/E: —

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary C…

Key Statistics

Company
Market Cap1.87M USD
Enterprise Value-663.24K USD
Revenue (TTM)1.50M USD
Gross Profit176.46K USD
Net Income (TTM)-10.52M USD
Revenue/Share0.0026 USD
Last Price0.0000 USD
Fiscal Year EndDec 2023
MR QuarterJun 2024
Employees20
CountryGB
SectorHealthcare
IndustryMedical Care Facilities
ISINGB00BYQCS703
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA0.19
EV/Revenue-0.44
P/S1.25
P/B0.25
EPS (TTM)-0.01 USD
EPS (Forward)—
52W Range
0.00000% of range0.0030
52W High0.0030 USD
52W Low0.0000 USD
Profitability
Gross Margin14.97%
Oper. Margin-317.11%
EBITDA Margin-236.75%
Profit Margin-892.40%
ROE-106.31%
ROA-95.64%
ROIC-49.30%
ROCE-39.31%
Growth
Revenue Growth54.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.32M USD
CapEx (TTM)701.88K USD
FCF Margin-74.81%
FCF Yield-59.94%
Net Debt-2.48M USD
Net Debt/EBITDA0.70
Net Debt/FCF—
Balance Sheet
Debt/Equity0.04
Current Ratio2.78
Quick Ratio2.72
Book Value/Sh0.01 USD
Cash/Share0.0040 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.632.43M
Float378.80M
Insiders3.43%
Institutions0.05%
Technical
SMA 500.0000 (-0.0%)
SMA 2000.0001 (-79.8%)
Beta2.27
S&P 52W Chg12.08%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)0.0
MACD-0.0619
MACD Signal-0.0479
MACD Hist.-0.0140
BB Upper0.0046 USD
BB Middle0.0016 USD
BB Lower-0.0014 USD
BB Width364.52%
ATR (14)0.0001 USD
Vol Ratio (20d)—

About Kanabo Group (LON: KNB)

›

Kanabo Group (LON: KNB) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 20 employees.

The shares were at 0.0022 GBp on 18 November 2026, down 99.0% over 52 weeks. Its 52-week range is 0.0022 GBp to 0.2250 GBp, and it trades at the bottom of that range.

Its market capitalisation is 1.42M GBP.

Kanabo Group reports return on equity of -106.3%, an operating margin of -317.1% and revenue up 54.6% year over year.

It holds more cash than debt, a net cash position of 1.88M GBP. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.